🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementNausea incidence by dose tier — 6 month update

Nausea incidence by dose tier — 6 month update

Dr.LeslieOBGYN Thu, Aug 7, 2025 at 3:48 PM 12 replies 1,370 viewsPage 1 of 3
This thread is more than 10 months old. Information may be outdated. Consider searching for more recent discussions.
Dr.LeslieOBGYN
Member
567
2,567
May 2024
Dallas, TX
Aug 7, 2025 at 3:48 PM#1

The nausea I get is not really nausea, it is an aversion. Food I want in the abstract becomes repellent in front of me, which no side-effect list describes.

What I am after is whether holding at a lower dose for longer actually reduces total side-effect burden or just spreads it out.

I would rather have one careful answer than five confident ones.

20 15Dr.BariatricHTX, LindaRN_retired, tommy_boulder and 17 others
Reply Quote Save Share Report
Dr.LipidDallas
VIP Member
2,678
14,567
Dec 2023
Dallas, TX
Aug 7, 2025 at 4:53 PM#2

This one has a reasonably settled answer, so here it is. The line between titrate-through and stop is not severity, it is trajectory and what else is present. Nausea that peaks and improves within a week is the expected pattern. Nausea that is escalating, or that comes with severe upper-abdominal pain radiating to the back, or that prevents fluids for more than a day, is a different conversation and belongs with a clinician the same day.

19 14wei_SG, cory_ATX, lori_vegas and 16 others
Reply Quote Save Share Report
Dr.AddMedPHL
Senior Member
1,234
6,234
Mar 2024
Philadelphia, PA
Aug 7, 2025 at 5:58 PM#3
Dr.LipidDallas said:
The line between titrate-through and stop is not severity, it is trajectory and what else is present.

Agreed on adaptation, with a caveat: adaptation applies to gastric emptying and not to everything. If your problem is the aversion rather than the fullness, waiting does less, because the aversion is central and it is the mechanism working as intended.

18 13mike.trainer_LA, sarah_nash92, FitDadDave and 15 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
LondonLisa
Member
912
3,456
Mar 2024
London, UK
Aug 7, 2025 at 7:03 PM#4
Dr.LeslieOBGYN said:
The nausea I get is not really nausea, it is an aversion.

Same position here, arrived at the long way round. The practical protocol is dull and it works: smaller meals, stop eating at the first sign of fullness rather than at the end of the plate, drop the fat fraction of meals in the two days after dosing, and do not lie down straight after eating. Most of what people call unmanageable nausea is a meal-size and meal-composition problem interacting with a stomach that is emptying slowly.

17 12JenPlateau, SallyK_inj, CryptoCarl and 14 others
Reply Quote Save Share Report
MASHdoc_SA
Member
456
2,345
Aug 2024
San Antonio, TX
Aug 8, 2025 at 1:14 AM#5

From the other side of the consultation, briefly. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

16 11kate.chem, DataDave, Dr.GutHealth and 13 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register